References
- Wiseman AC. Immunosuppressive Medications. Clinical journal of the American Society of Nephrology: CJASN. 2016;11:332–43. doi:https://doi.org/10.2215/CJN.08570814. PMID:26170177
- Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009; 373:1550–61. doi:https://doi.org/10.1016/S0140-6736(09)60237-3. PMID:19282026
- Chinen J, Buckley RH. Transplantation immunology: solid organ and bone marrow. J Allergy Clin Immunol.. 2010; 125:S324–35. doi:https://doi.org/10.1016/j.jaci.2009.11.014. PMID:20176267
- Fishman JA. Infections in immunocompromised hosts and organ transplant recipients: Essentials. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011;17(Suppl 3):S34–7. doi:https://doi.org/10.1002/lt.22378. PMID:21748845
- van Sandwijk MS, Bemelman FJ, Ten Berge IJ. Immunosuppressive drugs after solid organ transplantation. Neth J Med. 2013;71:281–9. PMID:23956308
- Reichenspurner H. Overview of tacrolimus-based immunosuppression after heart or lung transplantation. J Heart Lung Transplant. 2005;24:119–30. doi:https://doi.org/10.1016/j.healun.2004.02.022. PMID:15701425
- Duncan MD, Wilkes DS. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections. Proc Am Thorac Soc. 2005;2:449–55. doi:https://doi.org/10.1513/pats.200507-073JS. PMID:16322599
- Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB. Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med. 1984;101:667–82. doi:https://doi.org/10.7326/0003-4819-101-5-667. PMID:6385799
- Neofytos D, Fishman JA, Horn D, Anaissie E, Chang CH, Olyaei A, Pfaller M, Steinbach WJ, Webster KM, Marr KA. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2010;12:220–9. doi:https://doi.org/10.1111/j.1399-3062.2010.00492.x. PMID:20113459
- Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100:4358–66. doi:https://doi.org/10.1182/blood-2002-05-1496. PMID:12393425
- Tharayil John G, Shankar V, Talaulikar G, Mathews MS, Abraham Abraham M, Punnakuzhathil Thomas P, Korula Jacob C. Epidemiology of systemic mycoses among renal-transplant recipients in India. Transplantation. 2003;75:1544–51. doi:https://doi.org/10.1097/01.TP.0000061610.34110.04. PMID:12792512
- Kwon-Chung KJ, Sugui JA. Aspergillus fumigatus-what makes the species a ubiquitous human fungal pathogen? PLoS pathogens. 2013;9:e1003743. doi:https://doi.org/10.1371/journal.ppat.1003743. PMID:24348239
- Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11:275–88. doi:https://doi.org/10.1038/nri2939. PMID:21394104
- Akoumianaki T, Kyrmizi I, Valsecchi I, Gresnigt MS, Samonis G, Drakos E, Boumpas D, Muszkieta L, Prevost MC, Kontoyiannis DP, et al. Aspergillus Cell Wall Melanin Blocks LC3-Associated Phagocytosis to Promote Pathogenicity. Cell Host Microbe. 2016;19:79–90. doi:https://doi.org/10.1016/j.chom.2015.12.002. PMID:26749442
- Bhatia S, Fei M, Yarlagadda M, Qi Z, Akira S, Saijo S, Iwakura Y, van Rooijen N, Gibson GA, St Croix CM, et al. Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS One. 2011;6:e15943. doi:https://doi.org/10.1371/journal.pone.0015943. PMID:21246055
- Knox BP, Huttenlocher A, Keller NP. Real-time visualization of immune cell clearance of Aspergillus fumigatus spores and hyphae. Fungal Genet Biol. 2017;105:52–4. doi:https://doi.org/10.1016/j.fgb.2017.05.005. PMID:28559109
- Zarember KA, Sugui JA, Chang YC, Kwon-Chung KJ, Gallin JI. Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. J Immunol. 2007;178:6367–73. doi:https://doi.org/10.4049/jimmunol.178.10.6367. PMID:17475866
- Gazendam RP, van Hamme JL, Tool AT, Hoogenboezem M, van den Berg JM, Prins JM, Vitkov L, van de Veerdonk FL, van den Berg TK, Roos D, et al. Human Neutrophils Use Different Mechanisms To Kill Aspergillus fumigatus Conidia and Hyphae: Evidence from Phagocyte Defects. J Immunol. 2016;196:1272–83. doi:https://doi.org/10.4049/jimmunol.1501811. PMID:26718340
- Margalit A, Kavanagh K. The innate immune response to Aspergillus fumigatus at the alveolar surface. Fems Microbiol Rev. 2015;39:670–87. doi:https://doi.org/10.1093/femsre/fuv018. PMID:25934117
- Gazendam RP, van Hamme JL, Tool ATJ, Hoogenboezem M, van den Berg JM, Prins JM, Vitkov L, van de Veerdonk FL, van den Berg TK, Roos D, et al. Human Neutrophils Use Different Mechanisms To Kill Aspergillus fumigatus Conidia and Hyphae: Evidence from Phagocyte Defects. J Immunol. 2016;196:1272–83. doi:https://doi.org/10.4049/jimmunol.1501811. PMID:26718340
- Espinosa V, Rivera A. First Line of Defense: Innate Cell-Mediated Control of Pulmonary Aspergillosis. Front Microbiol. 2016;7:272. doi:https://doi.org/10.3389/fmicb.2016.00272. PMID:26973640
- Bendickova K, Tidu F, Fric J. Calcineurin-NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy. EMBO Mol Med. 2017;9:990–9. doi:https://doi.org/10.15252/emmm.201707698. PMID:28606994
- Greenblatt MB, Aliprantis A, Hu B, Glimcher LH. Calcineurin regulates innate antifungal immunity in neutrophils. J Exp Med. 2010;207:923–31. doi:https://doi.org/10.1084/jem.20092531. PMID:20421389
- Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, Birrell MA, Saijo S, Mostowy S, Shaunak S, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240–58. doi:https://doi.org/10.15252/emmm.201404556. PMID:25637383
- Shah A, Kannambath S, Herbst S, Rogers A, Soresi S, Carby M, Reed A, Mostowy S, Fisher MC, Shaunak S, et al. Calcineurin Orchestrates Lateral Transfer of Aspergillus fumigatus during Macrophage Cell Death. Am J Respir Crit Care Med. 2016;194:1127–39. doi:https://doi.org/10.1164/rccm.201601-0070OC. PMID:27163634
- Imbert S, Bresler P, Boissonnas A, Gauthier L, Souchet L, Uzunov M, Leblond V, Mazier D, Nguyen S, Fekkar A. Calcineurin inhibitors impair neutrophil activity against Aspergillus fumigatus in allogeneic hematopoietic stem cell transplant recipients. J Allergy Clin Immunol.. 2016;138:860–8. doi:https://doi.org/10.1016/j.jaci.2016.02.026. PMID:27132218
- Zelante T, Wong AY, Mencarelli A, Foo S, Zolezzi F, Lee B, Poidinger M, Ricciardi-Castagnoli P, Fric J. Impaired calcineurin signaling in myeloid cells results in downregulation of pentraxin-3 and increased susceptibility to aspergillosis. Mucosal Immunol. 2017;10:470–80. doi:https://doi.org/10.1038/mi.2016.52. PMID:27301880
- Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R, Maccagno A, Riva F, Bottazzi B, Peri G, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature. 2002;420:182–6. doi:https://doi.org/10.1038/nature01195. PMID:12432394
- Wong SSW, Rasid O, Laskaris P, Fekkar A, Cavaillon JM, Steinbach WJ, Ibrahim-Granet O. Treatment of Cyclosporin A retains host defense against invasive pulmonary aspergillosis in a non-immunosuppressive murine model by preserving the myeloid cell population. Virulence. 2017:1–9. https://doi.org/https://doi.org/10.1080/21505594.2017.1339007
- Stewart AA, Ingebritsen TS, Manalan A, Klee CB, Cohen P. Discovery of a Ca2+- and calmodulin-dependent protein phosphatase: probable identity with calcineurin (CaM-BP80). FEBS Lett. 1982;137:80–4. doi:https://doi.org/10.1016/0014-5793(82)80319-0. PMID:6279434
- Juvvadi PR, Lee SC, Heitman J, Steinbach WJ. Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach. Virulence. 2017;8:186–97. doi:https://doi.org/10.1080/21505594.2016.1201250. PMID:27325145
- Steinbach WJ, Schell WA, Blankenship JR, Onyewu C, Heitman J, Perfect JR. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Ch. 2004;48:1664–9. doi:https://doi.org/10.1128/AAC.48.5.1664-1669.2004.
- Snydman DR. Epidemiology of infections after solid-organ transplantation. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2001;33(Suppl 1):S5–8. doi:https://doi.org/10.1086/320897. PMID:11389515